Drug company and government officials announced new efforts designed to fight opioid addiction during a meeting of the President’s Commission on Combating Drug Addiction and the Opioid Crisis.

The National Institutes of Health (NIH) is seeking to build partnerships to find non-addictive alternatives to opioids for treating pain, according to NIH Director Dr. Francis Collins.

Stephen Ubl, CEO of the Pharmaceutical Research and Manufacturers of America, told the commission it will support limiting the supply of opioids to seven days, instead of the traditional 30-day supply for short-term pain relief and minor treatments.

The senior director of U.S. WorldMed told the commission the company is awaiting feedback from the Food and Drug Administration on their new drug Lofexidine. If approved, the drug would be the first and only non-narcotic product used for treating opioid withdrawal, CBS News reports.